FRANCESCO ROMANO | FCI | GW1516 METABOLITES | 2.1 - 2.2 | 3 years | accordo ex art. 11.8.1 CSA del 17/05/2024 | 16/04/2024 - 15/04/2027 |
EMANUELE LITRICO | FCI | 2.3 | 3 years | accordo ex art. 11.8.1 CSA del 28/06/2024 | 05/06/2024 - 04/06/2027 | |
DANILO DI VINCENZO | FCI | CLOSTEBOL METABOLITE - TUAMINOHEPTANE - CHLORTALIDONE | 2.1 - 2.2 | 2 yearse 1 month | decisione PNA del 24/07/2024 | 09/07/2024 - 08/08/2026 |
MARCO MAZZONI | FCI | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA (CERA) | 2.1 - 2.2 | 3 years | accordo ex art. 11.8.1 CSA del 26/07/2024 | 15/07/2024 - 14/7/2027 |
ANDREA ALBERTI | FIDAL | NON-ENDOGENOUS TESTOSTERONE AND ITS METABOLITES | 2.1 - 2.2 | 3 years | accordo ex art. 11.8.1 CSA del 30/07/2024 | 11/07/2024 - 10/07/2027 |
PIETRO MINA | FCI | RECOMBINANT ERYTHROPOIETIN | 2.1 - 2.2 | 7 years | accordo ex art. 11.8.1 CSA del 30/07/2024 | 11/07/2024 - 10/07/2031 |
FEDERICO FURIANI | FIDAL/FITRI | NON-ENDOGENOUS TESTOSTERONE METABOLITES; NON ENDOGENOUS BOLDENONE AND ITS METABOLITE | 2.1 - 2.2 | 5 years | accordo ex art. 11.8.1 CSA del 01/08/2024 | 26/05/2024 - 25/05/2029 |
DAVIDE PUGLIA | FCI | RECOMBINANT ERYTHROPOIETIN; SIBUTRAMINE | 2.1 - 2.2 | 7 years e 6 months | accordo ex art. 11.8.1 CSA del 02/08/2024 | scadenza il 10/01/2032 |
ENRICO MARIO BENES | FISPES | CANRENONE | 2.1 - 2.2 | 10 months | decisione PNA del 05/08/2024 | 29/06/2024 - 28/04/2025 |
GIUSEPPE LA ROCCA | FCI | RECOMBINANT ERYTHROPOIETIN; METANDIENONE METABOLITES; ANDROSTENEDIONE AND ITS METABOLITES (NON-ENDOGENOUS BOLDENONE AND BOLDENONE METABOLITE) | 2.1 - 2.2 (2^ violazione) | 16 years | decisione PNA del 05/08/2024 | 12/07/2024 - 11/07/2040 |
ALESSANDRO GAUDIO | FCI | CLENBUTEROL; 4-METHYLHEXAN-2-AMINE | 2.1 - 2.2 | 4 years | accordo ex art. 11.8.1 CSA del 28/08/2024 | 16/07/2024 - 15/07/2028 |
GIACOMA CORDIO | FPI | 2.3 | 2 years e 6 months | decisione PNA del 29/08/2024 | 13/08/2024 - 12/02/2027 | |
GIUSEPPINA MICHELA BERGOZZA | FCI | RECOMBINANT ERYTHROPOIETIN | 2.1 - 2.2 | 3 years | accordo ex art. 11.8.1 CSA del 06/09/2024 | 15/07/2024 - 14/07/2027 |
FEDERICO ALIANO | FIPE | IENOBOSARM (OSTARINE) AND ITS METABOLITE | 2.1 - 2.2 | 5 years | accordo ex art. 11.8.1 CSA del 06/09/2024 | 23/07/2024 - 22/07/2029 |
FRANCESCO MARTUCCI | FCI | COCAINE AND ITS METABOLITE BENZOYLECGONINE | 2.1 - 2.2 | 3 years | accordo ex art. 11.8.1 CSA del 13/09/2024 | 26/08/2024 - 25/08/2027 |
MASSIMO RUBINO | FCI | 11.14 | 16 years | decisione PNA del 12/09/2024 | 20/03/2049 - 19/03/2065 | |
GIUSTOLISI GIUSEPPE | FCI | RECOMBINANT ERYTHROPOIETIN | 2.1 - 2.2 | 3 years | accordo ex art. 11.8.1 CSA del 25/09/2024 | 19/09/2024 - 18/09/2027 |
CARMINE AMENDOLA | FCI | CLOSTEBOL METABOLITE | 2.1 - 2.2 | 1 year | decisione PNA del 26/09/2024 | 26/08/2024 - 25/08/2025 |
NICOLA MARCIANO' | FIPE | 2.9 | 2 years | decisione PNA del 02/10/2024 | 01/10/2024 - 30/09/2026 | |
ANGELO BOCCA | FIGC | 2.9 | 2 years | decisione PNA del 29/10/2024 | 28/10/2024 - 27/10/2026 | |
GIUSEPPE SCALONE | FCI | 19-NORANDROSTERONE >15 ng/mL - 19-NORETIOCHOLANOLONE |
2.1 - 2.2 | 4 years | decisione PNA del 21/11/2024 | 17/10/2024 - 16/10/2028 |
ANDRIA BITADZE | FIN | CLOSTEBOL METABOLITE | 2.1 - 2.2 | 13 months | decisione PNA del 20/12/2024 | 15/11/2024 - 14/12/2025 |
ISHARA UPEKA JAYAMANNAGE | F.CR.I | CANRENONE | 2.1 - 2.2 | 6 months | decisione PNA del 08/01/2025 | 14/11/2024 - 13/05/2025 |